中国医学创新
中國醫學創新
중국의학창신
Medical Innovation of China
2015年
28期
5-7
,共3页
Galetin-3%急性心梗%心衰%预测价值%阿托伐他汀
Galetin-3%急性心梗%心衰%預測價值%阿託伐他汀
Galetin-3%급성심경%심쇠%예측개치%아탁벌타정
Galetin-3%Acute myocardial infarction%Heart failure%Predictive value%Atorvastatin
目的:研究Galetin-3与急性心梗后NYHA心功能分级关系及阿托伐他汀对其干预作用。方法:选择2012年5月-2014年5月本院入院治疗的100例急性心梗患者作为试验研究对象,以随机数字法将所有患者分为观察组和对照组,每组各50例。再选取50例于本院进行体检结果显示健康人员作为健康组。观察组患者使用阿托伐他汀药物治疗,对照组患者使用临床普通的抗心衰药物治疗,观察两组急性心梗后心衰的干预情况,并对所有患者体内的Galetin-3水平进行检测,分析其对于急性心梗后心衰发生的预测价值。结果:两组治疗后Galetin-3含量均明显下降,但观察组患者下降更加明显,较对照组差异具有统计学意义(P<0.05)。治疗前,两组患者心功能指标水平比较差异无统计学意义(P>0.05);治疗后,两组的心功能水平较治疗前得到明显缓解,差异具有统计学意义(P<0.05)。治疗后,两组患者炎症因子TNF-α、IL-6以及Hs-CRP水平均明显下降,并且观察组的下降程度明显高于对照组,比较差异具有统计学意义(P<0.05)。不同NYHA分级患者NT-proBNP水平变化比较,等级为Ⅰ级时,治疗前后比较差异无统计学意义(P>0.05),其他级别治疗后NT-proBNP水平明显下降,比较差异有统计学意义(P<0.05)。结论:Galetin-3对急性心梗后心衰发生的预测具有十分重要的意义,并且使用阿托伐他汀对其干预作用效果较为显著,值得临床推广应用。
目的:研究Galetin-3與急性心梗後NYHA心功能分級關繫及阿託伐他汀對其榦預作用。方法:選擇2012年5月-2014年5月本院入院治療的100例急性心梗患者作為試驗研究對象,以隨機數字法將所有患者分為觀察組和對照組,每組各50例。再選取50例于本院進行體檢結果顯示健康人員作為健康組。觀察組患者使用阿託伐他汀藥物治療,對照組患者使用臨床普通的抗心衰藥物治療,觀察兩組急性心梗後心衰的榦預情況,併對所有患者體內的Galetin-3水平進行檢測,分析其對于急性心梗後心衰髮生的預測價值。結果:兩組治療後Galetin-3含量均明顯下降,但觀察組患者下降更加明顯,較對照組差異具有統計學意義(P<0.05)。治療前,兩組患者心功能指標水平比較差異無統計學意義(P>0.05);治療後,兩組的心功能水平較治療前得到明顯緩解,差異具有統計學意義(P<0.05)。治療後,兩組患者炎癥因子TNF-α、IL-6以及Hs-CRP水平均明顯下降,併且觀察組的下降程度明顯高于對照組,比較差異具有統計學意義(P<0.05)。不同NYHA分級患者NT-proBNP水平變化比較,等級為Ⅰ級時,治療前後比較差異無統計學意義(P>0.05),其他級彆治療後NT-proBNP水平明顯下降,比較差異有統計學意義(P<0.05)。結論:Galetin-3對急性心梗後心衰髮生的預測具有十分重要的意義,併且使用阿託伐他汀對其榦預作用效果較為顯著,值得臨床推廣應用。
목적:연구Galetin-3여급성심경후NYHA심공능분급관계급아탁벌타정대기간예작용。방법:선택2012년5월-2014년5월본원입원치료적100례급성심경환자작위시험연구대상,이수궤수자법장소유환자분위관찰조화대조조,매조각50례。재선취50례우본원진행체검결과현시건강인원작위건강조。관찰조환자사용아탁벌타정약물치료,대조조환자사용림상보통적항심쇠약물치료,관찰량조급성심경후심쇠적간예정황,병대소유환자체내적Galetin-3수평진행검측,분석기대우급성심경후심쇠발생적예측개치。결과:량조치료후Galetin-3함량균명현하강,단관찰조환자하강경가명현,교대조조차이구유통계학의의(P<0.05)。치료전,량조환자심공능지표수평비교차이무통계학의의(P>0.05);치료후,량조적심공능수평교치료전득도명현완해,차이구유통계학의의(P<0.05)。치료후,량조환자염증인자TNF-α、IL-6이급Hs-CRP수평균명현하강,병차관찰조적하강정도명현고우대조조,비교차이구유통계학의의(P<0.05)。불동NYHA분급환자NT-proBNP수평변화비교,등급위Ⅰ급시,치료전후비교차이무통계학의의(P>0.05),기타급별치료후NT-proBNP수평명현하강,비교차이유통계학의의(P<0.05)。결론:Galetin-3대급성심경후심쇠발생적예측구유십분중요적의의,병차사용아탁벌타정대기간예작용효과교위현저,치득림상추엄응용。
Objective:To study the relationship between Galetin-3 and NYHA after acute myocardial infarction and the intervention function of atorvastatin on the NYHA patients with after acute myocardial infarction. Method:100 patients with acute myocardial infarction in our hospital from May 2012 to May 2014 were randomly divided into observation group and control group,50 cases in each group,and 50 health cases as health group. The observation group was treated with atorvastatin,and the control group was treated with common anti heart failure drugs. The intervention of the two groups was observed after acute myocardial infarction,and the Galetin-3 levels of all patients were detected. Result:The Galetin-3 levels significantly decreased after treatment in the two groups,but the patients in the observation group were significantly lower than those in the control group(P<0.05). There were no significant differences in cardiac function index between the two groups before treatment(P>0.05),after treatment,the heart function level of the two groups was significantly relieved than before treatment,the difference was statistically significant(P<0.05)). After treatment,inflammatory factors TNF-α,IL-6 and Hs-CRP levels of the two groups patients significantly decreased,the difference was statistically significant(P<0.05),and the observation group was significantly higher than that of the control group,the difference was statistically significant(P<0.05). The different NYHA levels of NT-proBNP when was gradeⅠ, there was no difference before and after treatment(P>0.05),but significantly decreased in the other grade after treatment (P<0.05). Conclusion:Galetin-3 has a very important significance in predicting the occurrence of heart failure after acute myocardial infarction,and the effect of atorvastatin is more significant,which is worthy of clinical application.